» Articles » PMID: 26210813

Mapping of Brain Macromolecules and Their Use for Spectral Processing of (1)H-MRSI Data with an Ultra-short Acquisition Delay at 7 T

Overview
Journal Neuroimage
Specialty Radiology
Date 2015 Jul 27
PMID 26210813
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Long echo time (TE) MR spectroscopy (MRS) sequences are sensitive only to metabolites of low molecular weight. At shorter TE, significantly more metabolite signals are detectable, including broad signals of high-molecular-weight macromolecules (MMs). Although the presence of MM resonances can bias metabolite quantification at short TE, proper quantification of MMs is important since MMs themselves may serve as potentially valuable biomarkers for many pathologies. We have therefore developed an FID-based 2D-MR Spectroscopic Imaging (2D-MRSI) sequence to map MMs in healthy brain tissue at 7 T within a scan time of ~17 min and a repetition time of 879 ms. This 2D-MRSI technique provides MM maps over a whole slice (i.e., including cortical gray matter) at an ultra-short acquisition delay of 1.3 ms, using double inversion for efficient nulling of low-molecular-weight metabolites. The optimal sequence parameters were estimated using Bloch simulations, phantom testing, and in vivo validation. The acquired in vivo MM spectra (n=6) included nine distinct MM peaks in the range of ~0.9-3.7 ppm. The measured average MM spectrum was incorporated into the LCModel basis set and utilized for further quantification of MRSI data sets without metabolite nulling, which were acquired in five additional volunteers. The quantification results for two basis sets, one including the MMs and one without MM spectrum, were compared. Due to the high spectral resolution and full signal detection provided by the FID-MRSI sequence, we could successfully map five important brain metabolites. Most quantified metabolite signal amplitudes were significantly lower since the inclusion of MMs into the basis set corrected the overestimation of metabolite signals. The precision of fit (i.e., Cramér Rao lower bounds) remained unchanged. Our MM maps show that the overall MM contribution was higher in gray matter than in white matter. In conclusion, the acquired MM spectrum improved the accuracy of metabolite quantification and allowed the acquisition of high spatial resolution maps of five major brain metabolites and also MMs.

Citing Articles

Exploring in vivo human brain metabolism at 10.5 T: Initial insights from MR spectroscopic imaging.

Hingerl L, Strasser B, Schmidt S, Eckstein K, Genovese G, Auerbach E Neuroimage. 2025; 307:121015.

PMID: 39793640 PMC: 11906155. DOI: 10.1016/j.neuroimage.2025.121015.


WALINET: A water and lipid identification convolutional neural network for nuisance signal removal in MR spectroscopic imaging.

Weiser P, Langs G, Motyka S, Bogner W, Courvoisier S, Hoffmann M Magn Reson Med. 2024; 93(4):1430-1442.

PMID: 39737778 PMC: 11782715. DOI: 10.1002/mrm.30402.


Macromolecule Modelling for Improved Metabolite Quantification Using Short Echo Time Brain H-MRS at 3 T and 7 T: The PRaMM Model.

DellOrco A, Riemann L, Ellison S, Aydin S, Goschel L, Ittermann B NMR Biomed. 2024; 38(1):e5299.

PMID: 39701127 PMC: 11658865. DOI: 10.1002/nbm.5299.


Proton-free induction decay MRSI at 7 T in the human brain using an egg-shaped modified rosette K-space trajectory.

Blomer S, Hingerl L, Marjanska M, Bogner W, Motyka S, Hangel G Magn Reson Med. 2024; 93(4):1443-1457.

PMID: 39568225 PMC: 11782714. DOI: 10.1002/mrm.30368.


Examination of methods to separate overlapping metabolites at 7T.

Bell T, Goerzen D, Near J, Harris A Magn Reson Med. 2024; 93(2):470-480.

PMID: 39344348 PMC: 11604845. DOI: 10.1002/mrm.30293.